Entering text into the input field will update the search result below

Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q1 2021 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET

Company Participants

Todd Tushla - Vice President, Investor Relations

Kevin Gorman - Chief Executive Officer

Matt Abernethy - Chief Financial Officer

Eiry Roberts - Chief Medical Officer

Eric Benevich - Chief Commercial Officer

Conference Call Participants

Brian Abrahams - RBC Capital

Paul Matteis - Stifel

Phil Nadeau - Cowen & Company

Brian Skorney - Baird

Josh Schimmer - Evercore ISI

Neena Bitritto-Garg - Citi

Jay Olson - Oppenheimer

Anupam Rama - JPMorgan

Carter Gould - Barclays

Myles Minter - William Blair

Vamil Divan - Mizuho Securities

Marc Goodman - SVB Leerink

Laura Chico - Wedbush Securities


Good day, everyone, and welcome to today's Neurocrine Biosciences Reports First Quarter Results. At this time, all participants are in a listen-only mode. Later, you'll have the opportunity to ask questions during the question-and-answer session. [Operator Instructions] Please note, this call may be recorded. I will be standing by, if you need any assistance.

It is now my pleasure to turn the conference over to Vice President of Investor Relations, Todd Tushla. Please go ahead.

Todd Tushla

Thanks, Clay. Good afternoon, and thank you for joining us on our First Quarter 2021 Earnings Call. Here with me today is Kevin Gorman, our Chief Executive Officer; Matt Abernethy, our Chief Financial Officer; Eiry Roberts, our Chief Medical Officer; Eric Benevich, our Chief Commercial Officer; and Kyle Gano, our Chief Business Development and Strategy Officer.

I'll remind everyone that during today's call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to review the risk factors discussed in our latest SEC filings. Following our prepared remarks, we'll then head into Q&A.

With that, I'll turn

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About NBIX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on NBIX

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.